Martina Moschella
A5029319623- Pulmonary Hypertension Research and Treatments
- Cardiovascular Issues in Pregnancy
- Cardiac Valve Diseases and Treatments
- Transplantation: Methods and Outcomes
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Organ and Tissue Transplantation Research
- SARS-CoV-2 and COVID-19 Research
- ECG Monitoring and Analysis
- Mechanical Circulatory Support Devices
- Cardiovascular Function and Risk Factors
- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Vascular Anomalies and Treatments
- Emergency and Acute Care Studies
Ospedali Riuniti Umberto I
2025
Policlinico San Matteo Fondazione
2019-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2019-2024
Zimmer Biomet (United States)
2020
Question addressed by the study The clinical and prognostic role of tricuspid valve regurgitation (TR) in patients with pulmonary arterial hypertension (PAH) is still underappreciated. main objective present was to assess value TR incident PAH patients. Methods Consecutive were enrolled from 2011 2021. Patients underwent right heart catheterization (RHC), CPET, echocardiography including degree TR, annular plane systolic excursion (TAPSE), ratio TAPSE artery pressure (TAPSE/PASP),...
The correlation between myocardial injury and clinical outcome in COVID-19 patients is gaining attention the literature. aim of present study was to evaluate role cardiac involvement respiratory failure a cohort hospitalized an academic hospital Lombardy, one most affected Italian (and worldwide) regions by epidemic. included 405 consecutive with confirmed admitted medical ward from February 25th March 31st, 2020. Follow-up surviving ended either at discharge or July 30th, Myocardial defined...
Abstract Aim Low–density lipoprotein (LDL) cholesterol is a modifiable risk factor for cardiovascular disease and peripheral arteriopathy. Our aim to present real world analysis of lipid profile lipid–lowering therapy in patients admitted our vascular surgery department, invasive treatment artery (PAD). Methods We enrolled 399 from January 2023 February 2024: 236 with lower limbs arteriopathy 163 carotid Clinical features LDL value were collected. The percentage receiving statin the...
Abstract Aim To obtain real-world evidence about the features and risk stratification of pulmonary arterial hypertension (PAH) with a left heart disease (LHD) phenotype (PAH-LHD). Methods results By reviewing records consecutive incident PAH patients at 7 tertiary centers from 2001 to 2021, we selected 286 subjects all parameters needed determine death baseline first follow-up COMPERA 2.0 scores. Fifty seven (20%) had PAH-LHD according AMBITION definition. Compared no-LHD ones, they were...
Abstract Introduction Subclinical left heart disease (LHD) may impact the management of pulmonary arterial hypertension (PAH) [1]. Purpose To evaluate influence a LHD phenotype on PAH risk stratification. Methods We retrospectively reviewed data consecutive patients followed at 7 tertiary centers from 2001 to 2021, and selected those with all parameters available determine death by means COMPERA 2.0 scores, both baseline first reassessment including right catheterization. These subjects were...
Abstract Background Improved outcomes after percutaneous edge-to-edge mitral valvuloplasthy with MitraClip implantation were recently observed in patients heart failure (HF) and functional severe regurgitation (MR). Nonetheless, its efficacy end-stage are lacking. Purpose Our aim was to investigate feasibility, preliminary on hemodynamics follow-up of a cohort very advanced HF. Methods Patients retrospectively included the present analysis if already HT list, unsuitable for despite optimal...
Abstract Introduction Pulmonary arterial hypertension (PAH) is a rare and progressive disease with high morbidity mortality rate its prognosis critically affected by right ventricle (RV) dysfunction. Several studies have demonstrated that the presence of moderate-severe tricuspid regurgitation (TR) associated poor in PAH. However, echocardiographic correlates impact on functional capacity significant TR PAH patients not been thoroughly investigated. Purpose The aims this study were to...
Abstract Background Risk scores are important tools for the prognostic stratification of pulmonary arterial hypertension (PAH). Their performance and additional impact comorbidities across age groups is unknown. Methods Patients with PAH enrolled from 2001 to 2021 were divided in ≥ 65 years old vs <65 patients. Study outcome was 5-year all-cause mortality. FPHN, FPHN non-invasive, COMPERA REVEAL 2.0 risk calculated patients categorized at low, intermediate high risk. Number...